Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasushi Takamori

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Medical and Dental Sciences|May 5, 2005
Granulysin induces cell death with nuclear accumulationYasushi Takamori, Kazuyuki Ogawa, Kinya Nagata, et al.
Cancer Immunology, Immunotherapy : CII|January 25, 2002
Differential expression of granulysin and perforin by NK cells in cancer patients and correlation of impaired granulysin expression with progression of cancerAtsuko Kishi, Yasushi Takamori, Kazuyuki Ogawa, et al.
The American Journal of Pathology|August 9, 2008
Granulysin produced by uterine natural killer cells induces apoptosis of extravillous trophoblasts in spontaneous abortionAkitoshi Nakashima, Arihiro Shiozaki, Subaru Myojo, et al.
European Journal of Immunology|July 30, 2003
Granulysin in human serum as a marker of cell-mediated immunityKazuyuki Ogawa, Yasushi Takamori, Kunou Suzuki, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|July 1, 2011
Efficacy of Brazilian Propolis against Herpes Simplex Virus Type 1 Infection in Mice and Their Modes of Antiherpetic EfficaciesTomomi Shimizu, Youhei Takeshita, Yasushi Takamori, et al.
Human Vaccines & Immunotherapeutics|December 20, 2012
Novel therapeutic vaccines [(HSP65 + IL-12)DNA-, granulysin- and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapyYoko Kita, Satomi Hashimoto, Toshihiro Nakajima, et al.
Human Vaccines & Immunotherapeutics|December 20, 2012
The study of novel DNA vaccines against tuberculosis: induction of pathogen-specific CTL in the mouse and monkey models of tuberculosisMasaji Okada, Yoko Kita, Toshihiro Nakajima, et al.
Human Vaccines|January 26, 2011
Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice modelsYoko Kita, Masaji Okada, Toshihiro Nakajima, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Medical and Dental Sciences|May 5, 2005
Granulysin induces cell death with nuclear accumulationYasushi Takamori, Kazuyuki Ogawa, Kinya Nagata, et al.
Cancer Immunology, Immunotherapy : CII|January 25, 2002
Differential expression of granulysin and perforin by NK cells in cancer patients and correlation of impaired granulysin expression with progression of cancerAtsuko Kishi, Yasushi Takamori, Kazuyuki Ogawa, et al.
The American Journal of Pathology|August 9, 2008
Granulysin produced by uterine natural killer cells induces apoptosis of extravillous trophoblasts in spontaneous abortionAkitoshi Nakashima, Arihiro Shiozaki, Subaru Myojo, et al.
European Journal of Immunology|July 30, 2003
Granulysin in human serum as a marker of cell-mediated immunityKazuyuki Ogawa, Yasushi Takamori, Kunou Suzuki, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|July 1, 2011
Efficacy of Brazilian Propolis against Herpes Simplex Virus Type 1 Infection in Mice and Their Modes of Antiherpetic EfficaciesTomomi Shimizu, Youhei Takeshita, Yasushi Takamori, et al.
Human Vaccines & Immunotherapeutics|December 20, 2012
Novel therapeutic vaccines [(HSP65 + IL-12)DNA-, granulysin- and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapyYoko Kita, Satomi Hashimoto, Toshihiro Nakajima, et al.
Human Vaccines & Immunotherapeutics|December 20, 2012
The study of novel DNA vaccines against tuberculosis: induction of pathogen-specific CTL in the mouse and monkey models of tuberculosisMasaji Okada, Yoko Kita, Toshihiro Nakajima, et al.
Human Vaccines|January 26, 2011
Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice modelsYoko Kita, Masaji Okada, Toshihiro Nakajima, et al.
Pageof 1